A recently released preprint study shows that expanded telehealth coverage did not lead to an increase in volume for outpatient E&M services.
Subscribe today for full access
to all of these articles.
Researchers are actively developing PRTs for use in whole blood products to target bacteria and viruses, including SARS-CoV-2.
NY federal court ruling sheds light on what constitutes “remuneration” banned by the Anti-Kickback Statute.
Partnership will make use of Illumina’s capabilities and expertise in large-scale genomic sequencing and quickly generate high-quality data.
Lawmakers blame pharmacy benefit managers for high drug prices, introducing a bill to prevent what they term unfair practices.
HHS pulls the plug on a Trump rule requiring regulations to expire automatically after 10 years.
In this week’s Labs in Court roundup, six physicians were accused of billing for unnecessary lab tests in connection with an earlier lab fraud complaint.
A systematic evidence-based review from the ACMG shows NIPS tests are an effective screening tool for general-risk pregnancies.
Lab employees who’ve worked from home may be less than willing to return to the facility, if the situation at Apple is anything to go by.
HHS will distribute OraSure’s InteliSwab COVID-19 rapid at-home antigen test kits to schools across the nation.
A recently developed bioelectronic tool could make health monitoring less invasive for babies in newborn intensive care units.
The algorithm, designed to help diagnose pulmonary hypertension earlier, aims to ensure patients get treatment sooner.